- Home
- DCGO vs CYBN Comparison
DCGO vs CYBN Comparison
Compare DCGO & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- CYBN
- Stock Information
- Founded
- DCGO 2015
- CYBN 2019
- Country
- DCGO United States
- CYBN Canada
- Employees
- DCGO N/A
- CYBN N/A
- Industry
- DCGO Managed Health Care
- CYBN Pharmaceuticals and Biotechnology
- Sector
- DCGO Health Care
- CYBN Health Care
- Exchange
- DCGO Nasdaq
- CYBN Nasdaq
- Market Cap
- DCGO 138.7M
- CYBN 127.3M
- IPO Year
- DCGO N/A
- CYBN N/A
- Fundamental
- Price
- DCGO $1.42
- CYBN $7.96
- Analyst Decision
- DCGO Strong Buy
- CYBN Strong Buy
- Analyst Count
- DCGO 4
- CYBN 4
- Target Price
- DCGO $3.74
- CYBN $86.00
- AVG Volume (30 Days)
- DCGO 1.7M
- CYBN 326.5K
- Earning Date
- DCGO 05-08-2025
- CYBN 06-25-2025
- Dividend Yield
- DCGO N/A
- CYBN N/A
- EPS Growth
- DCGO N/A
- CYBN N/A
- EPS
- DCGO N/A
- CYBN N/A
- Revenue
- DCGO $520,500,658.00
- CYBN N/A
- Revenue This Year
- DCGO N/A
- CYBN N/A
- Revenue Next Year
- DCGO $4.08
- CYBN N/A
- P/E Ratio
- DCGO N/A
- CYBN N/A
- Revenue Growth
- DCGO N/A
- CYBN N/A
- 52 Week Low
- DCGO $1.23
- CYBN $4.81
- 52 Week High
- DCGO $5.68
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- DCGO 33.29
- CYBN 61.23
- Support Level
- DCGO $1.23
- CYBN $7.00
- Resistance Level
- DCGO $1.53
- CYBN $8.50
- Average True Range (ATR)
- DCGO 0.10
- CYBN 0.53
- MACD
- DCGO 0.02
- CYBN 0.15
- Stochastic Oscillator
- DCGO 46.34
- CYBN 76.00
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.